The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)
Showing 1-20 of 46 articles
One- and two-year clinical outcomes of treatment with resorbable magnesium scaffolds for coronary artery disease: the prospective, international, multicentre BIOSOLVE-IV registry
Wlodarczak A,
Montorsi P,
Torzewski J,
Bennett J,
Starmer G,
Buck T,
Haude M,
Moccetti M,
Wiemer M,
Lee M,
Verheye S
May 24, 2023 | 10.4244/EIJ-D-22-01069
Evaluation of the R-One robotic system for percutaneous coronary intervention: the R-EVOLUTION study
April 3, 2023 | 10.4244/EIJ-D-22-00642
Effects of coronary sinus Reducer implantation on oxygen kinetics in patients with refractory angina
April 2, 2021 | 10.4244/EIJ-D-19-00766
Reply: Pitfalls in aerobic capacity estimation of a chronic angina population
March 19, 2021 | 10.4244/EIJ-D-20-00676R
Twelve-month clinical and imaging outcomes of the uncaging coronary DynamX bioadaptor system
Verheye S,
Vrolix M,
Montorfano M,
Zivelonghi C,
Giannini F,
Bedogni F,
Dubois C,
De Bruyne B,
Costa R,
Chamié D,
de Ribamar Costa J,
Kereiakes D,
Abizaid A,
Colombo A
December 18, 2020 | 10.4244/EIJ-D-20-00763
Five-year safety and performance data of a novel third-generation novolimus-eluting bioresorbable scaffold in single de novo lesions
Verheye S,
Costa R,
Schofer J,
Ormiston J,
Maeng M,
Dudek D,
Skurk C,
Botelho R,
Costa J,
Chamié D,
Abizaid An,
Boersma E,
Abizaid A
October 18, 2019 | 10.4244/EIJ-D-18-00292
Final five-year clinical outcomes in the EVOLVE trial: a randomised evaluation of a novel bioabsorbable polymer-coated, everolimus-eluting stent
Meredith I,
Verheye S,
Dubois C,
Dens J,
Farah B,
Carrié D,
Walsh S,
Oldroyd K,
Varenne O,
El-Jack S,
Moreno R,
Christen T,
Allocco D
April 20, 2018 | 10.4244/EIJ-D-17-00529
Long-term clinical outcomes of a crystalline sirolimus-eluting coronary stent with a fully bioabsorbable polymer coating: five-year outcomes from the DESSOLVE I and II trials
Wijns W,
Vrolix M,
Verheye S,
Schoors D,
Slagboom T,
Gosselink M,
Benit E,
Kandzar D,
Donohoe D,
Ormiston J
April 6, 2018 | 10.4244/EIJ-D-17-00230
Sustained safety and clinical performance of a drug-eluting absorbable metal scaffold up to 24 months: pooled outcomes of BIOSOLVE-II and BIOSOLVE-III
Haude M,
Ince H,
Kische S,
Abizaid A,
Toelg R,
Lemos P,
Van Mieghem N,
Verheye S,
von Birgelen C,
Christiansen E,
Wijns W,
Garcia-Garcia H,
Waksman R
July 20, 2017 | 10.4244/EIJ-D-17-00254
DESyne novolimus-eluting coronary stent is superior to Endeavor zotarolimus-eluting coronary stent at five-year follow-up: final results of the multicentre EXCELLA II randomised controlled trial
Iqbal J,
Verheye S,
Abizaid A,
Ormiston J,
De Vries T,
Morrison L,
Toyloy S,
Fitzgerald P,
Windecker S,
Serruys P
December 9, 2016 | 10.4244/EIJY15M10_04
Cryotherapy increases features of plaque stability in atherosclerotic rabbits
Verheye S,
Roth L,
De Meyer I,
Van Hove C,
Nahon D,
Santoianni D,
Yianni J,
Martinet W,
Buchbinder M,
De Meyer G
August 20, 2016 | 10.4244/EIJY15M10_02
Safety and performance of the DRug-Eluting Absorbable Metal Scaffold (DREAMS) in patients with de novo coronary lesions: 3-year results of the prospective, multicentre, first-in-man BIOSOLVE-I trial
Haude M,
Erbel R,
Erne P,
Verheye S,
Degen H,
Vermeersch P,
Weissman N,
Prati F,
Bruining N,
Waksman R,
Koolen J
June 10, 2016 | 10.4244/EIJ-D-15-00371
Impact of side branch stenting on five-year long-term clinical outcome with the bifurcation-dedicated Axxess Biolimus A9-eluting stent system
December 20, 2015 | 10.4244/EIJV11I8A176
Incidence and potential mechanism of resolved, persistent and newly acquired malapposition three days after implantation of self-expanding or balloon-expandable stents in a STEMI population: insights from optical coherence tomography in the APPOSITION II study
Nakatani S,
Onuma Y,
Ishibashi Y,
Karanasos A,
Regar E,
Garcia-Garcia H,
Tamburino C,
Fajadet J,
Vrolix M,
Witzenbichler B,
Eeckhout E,
Spaulding C,
Reczuch K,
La Manna A,
Spaargaren R,
Capodanno D,
van Langenhove G,
Verheye S,
Serruys P,
van Geuns R
December 20, 2015 | 10.4244/EIJY15M11_01
Percutaneous ventricular restoration (PVR) therapy using the Parachute device in 100 subjects with ischaemic dilated heart failure: one-year primary endpoint results of PARACHUTE III, a European trial
Thomas M,
Nienaber C,
Naber C,
Ince H,
Erglis A,
Vukcevic V,
Schäfer U,
Ferreira R,
Hardt S,
Verheye S,
Ribeiro V,
Sugeng L,
Tamburino C
October 20, 2015 | 10.4244/EIJV11I6A143
The Tiara transcatheter mitral valve implantation system
September 17, 2015 | 10.4244/EIJV11SWA20
Latest news
AHEAD OF PRINT
Ostial RCA ISR: mechanisms and treatment outcomes
FREE ARTICLE - Kei Yamamoto et al
June 7, 2023
AHEAD OF PRINT
Two-year outcomes after TMVR
FREE ARTICLE - Sebastian Ludwig et al
May 26, 2023
NEW ISSUE
Expert Review on Calcified CTOs; Calcified Nodules Revascularisation Debate; CTO PCI; Stent Failure and Calcified Nodules and more...
June 5, 2023
AHEAD OF PRINT
BIOSOLVE-IV registry
FREE ARTICLE - Adrian Wlodarczak et al
May 24, 2023
AHEAD OF PRINT EUROPCR
The EURO SHOCK Trial
FREE ARTICLE - Amerjeet Singh Banning et al
May 19, 2023
AHEAD OF PRINT EUROPCR
Early safety and feasibility of a first-in-class biomimetic transcatheter aortic valve (DurAVR)
FREE ARTICLE - Susheel K. Kodali et al
May 19, 2023
AHEAD OF PRINT EUROPCR
TAVI for bicuspid aortic valves with Evolut platform
FREE ARTICLE - Didier Tchétché et al
May 18, 2023